Should I buy Nucor (NUE) stock or is it too late?

Nucor · Materials · price $254

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 63% of its targets hit on this sector (185 calls tested). It aims for $256 (+0.9 %), call made on July 29, 2026, maturing on July 29, 2027 (77 d ago).

The 4 reliable analysts $295+16 %

The 6 other firms $280+10 %

How to read it: the 4 reliable firms are not filtered by optimism — 4 aim above the price, 0 below, hence their $295 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Nucor

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Keybanc	55 %	+37.0 %	11	$286 +13%
UBS	75 %	+25.4 %	8	$256 +1%
Morgan Stanley	75 %	+21.1 %	8	$258 +2%
JP Morgan	67 %	+21.1 %	18	$296 +17%
Jefferies	73 %	+19.4 %	11	$190 -25%
B of A Securities	57 %	+15.9 %	7	$280 +10%
Barclays	60 %	+3.9 %	5	$295 +16%
Citigroup	50 %	+3.6 %	6	$260 +2%

In short — Should you invest in Nucor? Is it too late, still worth it? Analysts are fairly positive (70% buy, median target $283, i.e. +11%), and the most reliable on NUE targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

70% of analysts rate it a buy (Buy consensus, 10 ratings) — a sign of market conviction.
Median price target $283, i.e. +11% from the current price ($254).
The most reliable firm on NUE, BMO Capital (100% hit rate, 2 scored calls), targets $295 (call made on July 29, 2026, maturing on July 29, 2027) (+16%) in its most recent call, and $235 (call made on April 28, 2026, maturing on April 28, 2027) (-7%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 10 ratings, 3 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on NUE

Median target $283 (+11%) · 10 ratings · Buy consensus

Strong Buy00%

Buy770%

Hold330%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Nucor now?

We won't decide for you. The facts: 70% of analysts rate it a buy, median target $283 (+11%), and BMO Capital (most reliable on NUE, 100%) targets $295. Weigh that against valuation (P/E ~20). This is not personalized advice.

Is it too late to invest in Nucor?

Not according to analysts: the median target ($283) is still +11% above the current price ($254) (most reliable on NUE: BMO Capital, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Nucor still worth investing in?

It depends on the gap between the price ($254) and its estimated value: analysts target $283 on median (+11%), with 70% buys (most reliable on NUE: BMO Capital, 100%). Cross-check with their real reliability on NUE and the cautions above. Information, not advice.

What's the main risk in buying NUE?

The consensus is not unanimous: of 10 ratings, 3 are neutral.

→ Go deeper: the full Nucor profile (consensus, analyst reliability, price target, performance).